FC
GPCR icon

FORA Capital’s Structure Therapeutics GPCR Stock Holding History

FORA Capital’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,327
Closed -$209K – 495
2024
Q2 		$209K Sell
5,327
-11,763
-69% -$483K 0.03% 346
2024
Q1 		$732K Buy
+17,090
New +$721K 0.06% 274

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FORA Capital's GPCR Position: Q3 2024 in Review

FORA Capital sold out of Structure Therapeutics (GPCR) in Q3 2024, closing a stake of 5,327 shares — an estimated $209K sold.

FORA Capital first reported a position in GPCR in Q1 2024 and held it in 2 quarters. The position peaked at $732K in Q1 2024. 160 funds tracked by Wall St. Rank hold GPCR as of Q3 2024.

  • FORA Capital reported no remaining Structure Therapeutics position as of Q3 2024 after selling out during the quarter.
  • FORA Capital sold 5,327 Structure Therapeutics shares in Q3 2024, an estimated $209K.
  • FORA Capital first reported a position in Structure Therapeutics in Q1 2024 and held it in 2 quarters.
  • FORA Capital's Structure Therapeutics position peaked at $732K in Q1 2024.
  • 160 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2024.

Based on FORA Capital's 13F filing for Q3 2024, filed 13 Nov 2024.